👉 Hit play. Think smarter. Laugh harder. Maybe even profit.
Many risk-tolerant investors love hunting for high-growth stocks under $10. Why? Because a small investment—sometimes just $1,000—can turn into massive gains.
Take Palladyne AI Corp. (NASDAQ: PDYN), for example. Investors who bought in six months ago have seen gains of over 480% as of February 19, 2025. And it wasn’t long ago that stocks like Palantir Technologies Inc. (NASDAQ: PLTR) were trading below $10 before skyrocketing.
Of course, not every stock under $10 is a winner. Some trade at low prices for a reason. But we’ve identified seven stocks that analysts are bullish on—backed by solid fundamentals and real growth potential.
Using the Nutstuff stock screener, we’ve pinpointed stocks under $10 that are projected to deliver at least 10% earnings growth in 2025.
Read on to discover these high-upside opportunities before the market catches on.
Green Thumb Industries (OTCMKTS:GTBIF)
Cannabis stocks? Still a wild ride. But big growth is coming, and not all players will survive. One that looks solid? Green Thumb Industries (GTBIF)—they sell the good stuff (legally) for both medical and recreational use.
Analysts say cannabis market growth will outpace beer and tobacco (because, let’s be real, people love their weed). But the feds still treat it like it’s the devil’s lettuce, making funding a headache.
Still, Wall Street likes GTBIF. Price target? $16.10—which means a potential 138% gain. Not a bad bet if you’ve got patience. Click here before everyone else catches on.
Green Thumb Industries (GTBIF) is basically the Amazon of weed—they grow it, package it, sell it, and even deliver it. They’ve got two main hustles: selling directly to customers through their own dispensaries and supplying third-party retailers.
Their lineup? Everything from flower to vapes to edibles—sold under brands like RHYTHM, Beboe, and Dogwalkers (because apparently, stoned dog walks are a thing).
Founded in 2014, based in Chicago, and growing like a well-fed houseplant. If cannabis keeps booming, GTBIF could be a serious winner.
Kion Group (OTCMKTS:KIGRY)
Some stocks dip under $10 but have serious comeback potential—and KION GROUP (KIGRY) might be one of them. They’re in the business of forklifts, automation tech, and supply chain wizardry, with brands like Dematic, Linde, and Still under their belt.
The company’s making real money, cutting debt, and getting back to pre-2020 levels. Investors noticed—the stock’s already up 26.9% in 2025.
One analyst thinks it could hit 50 Euros (~$52)—aka a 400% gain. Could be a steal at this price. Your move.
KION GROUP (KIGRY) is basically the king of forklifts and supply chain automation. They sell everything from forklifts to warehouse robots under brands like Linde, STILL, and Dematic—aka, the stuff that keeps global logistics moving.
They don’t just build machines; they lease, service, and finance them too. Oh, and they also make high-tech automated storage and retrieval systems (because warehouses don’t run themselves—yet).
Founded in 2006, based in Frankfurt, and quietly dominating the logistics game. If you believe in the future of automation, KION’s a name to watch.
Denison Mines (NYSEAMERICAN:DNN)
Denison Mines (DNN) digs up uranium, the stuff that keeps nuclear reactors humming—which, by the way, could be a huge deal as AI data centers suck up more power than a Vegas casino.
Uranium prices took a hit in 2024, but DNN stock held up well… until December, when tech stocks tanked, and China dropped its own AI model, making investors rethink the whole “AI needs endless power” narrative.
But let’s be real—AI isn’t going anywhere, and neither is the need for clean, 24/7 energy. Analysts still see DNN hitting $3, which would be an 89.2% gain.
If you’re betting on the future of energy, this might be worth a look.
Denison Mines (DNN) is in the uranium game—finding it, digging it up, and getting it ready to power nuclear reactors. Their big project? Wheeler River, a 300,000-hectare uranium hotspot in Saskatchewan’s Athabasca Basin.
They’ve been around since 1936, though they used to be called International Uranium Corporation (which, let’s be honest, sounds like a Bond villain front).
Now, they’re all-in on uranium—a key player in the future of clean energy. If nuclear power makes a comeback, DNN could be sitting on a goldmine (well… a uranium mine).
Hudbay Minerals (NYSE:HBM)
Hudbay Minerals (HBM) is a gold and copper miner with its big-money operation, Constancia, in Peru. They dig up a mix of metals, but gold (27% of revenue) and copper (62%) pay the bills.
2024 was a tale of two metals: Gold crushed it, copper… not so much. But 2025-2030? Copper’s time to shine. Why? Because the world needs it for EVs, AI data centers, and all things electrification.
Analysts are bullish on HBM, slapping a $10.93 price target on it—a 46.5% gain from here. If you believe in the future of metals, this one’s worth a look.
Hudbay Minerals (HBM) is a diversified miner that digs up copper, gold, silver, zinc, and molybdenum across North and South America. Their crown jewel? The Constancia mine in Peru—100% owned and packed with metal.
They’ve been in the game since 1927, based in Toronto, and still going strong. If you’re into commodities and believe metals are the future, HBM might be worth a spot on your watchlist.
Anavex Life Sciences (NASDAQ:AVXL)
Anavex Life Sciences (AVXL) is a classic high-risk, high-reward biotech play. No profits, no revenue—just a big bet on ANAVEX 2-73, a potential game-changer for Alzheimer’s and Parkinson’s.
The stock took off in December 2024 after Europe’s EMA agreed to review the drug. Not the same as FDA approval, but hey, traders got excited.
The gamble? EMA could say no. The upside? Analysts still have a $44 price target—a 411% gain from here. If you like moonshot biotech stocks, this one’s got serious potential.
Anavex Life Sciences (AVXL) is a biotech moonshot focused on brain diseases. Their star player? ANAVEX 2-73, a potential breakthrough for Alzheimer’s, Parkinson’s, and Rett syndrome (a rare neuro disorder).
They’ve also got ANAVEX 3-71 in trials for schizophrenia and dementia, plus a lineup of preclinical drugs targeting depression, pain, strokes, and even cancer.
Founded in 2004, HQ’d in NYC, and still pre-revenue—aka, high risk, high reward. If even one of these drugs hits, this stock could explode.
Vestas Wind Systems (OTCMKTS:VWDRY)
Vestas Wind Systems (VWDRY) is a wind power giant trading under $10—a classic contrarian play for growth investors. They design, build, and service wind turbines across the U.S., Denmark, and beyond.
The stock’s been sliding since October 2024 over fears that a Trump presidency = less love for wind energy. But here’s the twist: Vestas just reported a record order backlog, meaning 2025 revenue could surprise to the upside.
Analysts? Super bullish. They’ve slapped a $40.50 price target on it—an 800%+ upside. If you believe in wind’s long-term future, this might be a steal.
Vestas Wind Systems (VWDRY) is a wind energy powerhouse that builds, installs, and services wind turbines worldwide. They’ve got two main gigs: Power Solutions (wind farms, turbines) and Service (maintenance, spare parts, and keeping those giant blades spinning).
Founded in 1898 (yep, before electricity was even mainstream), headquartered in Denmark, and still one of the biggest names in wind.
If you think wind power isn’t going anywhere, Vestas is a name to know
Aspen Aerogels (NYSE:ASPN)
Aspen Aerogels (ASPN) makes high-tech insulation for lithium-ion batteries, putting it squarely in the EV game—which, let’s be honest, has been a rough ride lately.
Back in 2021, ASPN got caught up in the meme stock madness, soaring past $30 on EV hype. Fast forward to 2025? EV demand is cooling, and Aspen just paused construction on a Georgia plant because, well, scaling up isn’t a priority right now.
Short term? Flat growth. Long term? Maybe a different story. Analysts still see ASPN hitting $16—an 89.5% upside from here.
If you’ve got patience, this might be a bargain in the making.
Aspen Aerogels (ASPN) is in the business of insulation—really high-tech insulation. They make aerogel-based materials that keep things hot, cold, or fireproof across energy, EVs, aerospace, and industrial markets.
Their big moneymaker? PyroThin, a thermal barrier for lithium-ion batteries in EVs and energy storage. They also sell fire-resistant, cryogenic, and corrosion-fighting insulation for everything from offshore oil rigs to refrigerated appliances.
Founded in 2001, HQ’d in Massachusetts, and still a leader in cutting-edge insulation tech.
If you think EVs, clean energy, and industrial innovation are here to stay, Aspen’s a name to watch.
🔍 Buying stocks under $10 isn’t just FOMO trading—the smart money looks for undervalued companies with solid fundamentals.
One of the easiest ways to spot a bargain? Check what analysts are saying. Sure, they’re not always right, but they do their homework and base their targets on real numbers, not just hype.
That said, stocks don’t always follow the script (cough meme stocks cough), and companies aren’t always perfect at predicting their own future. But more often than not, analyst sentiment is a solid guide for where a stock is headed.
Moral of the story? Don’t ignore the pros. 📈
No Nonsense, Just Common Sense, Stock Ideas & Conclusions
Please let me know what you think of our newsletter!
Join 2+ million and follow us on social media for daily insights:
Twitter/ X: @nutstuffalpha
Youtube: Youtube.com/@NutstuffAlpha
Telegram: http://t.me/nutstuff
Website: https://www.nutstuff.co.uk/subscribe
➕Please add this newsletter to your contacts to ensure that none of our emails ever go to spam!
*Capital at risk, sophisticated investors only https://www.nutstuff.co.uk/disclaimer
Share this post